Bridgepoint has agreed to acquire a majority stake in GBA Group, a laboratory testing business headquartered in Hamburg, Germany. The deal marks a significant expansion for Bridgepoint, which has previously backed ten TIC platforms, including Element Materials Technology and LGC. In the transaction, Ardian will exit the vast majority of its stake, while GBA’s management remains invested. GBA provides testing across environmental, food, pharmaceuticals, medical device and cosmetics markets, serving more than 60,000 customers worldwide. The acquisition aligns with Bridgepoint’s strategy to deepen its presence in the global testing, inspection and certification sector. The transaction underscores the growing demand for rigorous quality assurance in critical industries and highlights Bridgepoint’s confidence in GBA’s strong market position.

Bridgepoint’s move into GBA’s established network of laboratories is expected to enhance service delivery and expand the firm’s capabilities in emerging markets. With the backing of a robust marrid of expertise and a proven track record in TIC platforms, Bridgepoint aims to scale GBA’s operations and drive innovation across its testing portfolio.

The acquisition also signals a broader trend of consolidation in the laboratory testing industry, as firms seek to bolster their service offerings and capitalise on increasing regulatory scrutiny worldwide.